Patient Recruitment Services and Patient Retention Services market 2022 – Industry Growth by 2035
Roots Analysis has done a detailed study on Patient Recruitment and Retention Services Market (3rd Edition), 2022-2035 covering key aspects of the industry evolution and identifying future growth opportunities.
berry_cristan
Key Market Insights
§ Currently, over 150 companies claim to offer patient recruitment and retention services to the pharmaceutical and medical device industries, using a variety of conventional and innovative outreach methods
§ The current market landscape is highly fragmented, featuring the presence of both new entrants and established players across key geographical regions
§ Most of the companies offer pre-screening of the potential study candidates and protocol development services to their clients; providing study-branded amenities is the most popular patient retention strategy
§ In order to gain a competitive edge and cater to the requirements of the clients, firms are actively improving their capabilities and enhancing their respective service portfolios
§ The increasing preference of trial sponsors to outsource patient recruitment-related activities is evident from the increase in partnership activity; in fact, more than 35% of the deals were forged in the last three years
§ Rising clinical research activity, specifically focused on rare and complex disease indications, is anticipated to create lucrative business opportunities for patient recruitment service and patient retention service providers
§ The demand for participants in clinical research is rising, and gradually becoming more complex owing to stringent regulatory guidelines; by 2035, around 21 million patients are expected to be enrolled in clinical trials
§ The market is expected to grow at a steady rate till 2035; the projected opportunity is likely to be well distributed across different steps in the patient recruitment process, trial phase and therapeutic area
§ In terms of annual service revenues, North America is likely to capture majority share in the patient recruitment market; however, Asia Pacific is anticipated to grow at a higher rate compared to other geographies
To get a sample copy of the latest market report, visit
https://www.rootsanalysis.com/reports/245/request-sample.html
Table of Contents
1. PREFACE
1.1. Scope of the Report
1.2. Market Segmentation
1.3. Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Clinical Trials
3.2.1 Clinical Trial Phases
3.3. Patient Recruitment in Clinical Trials
3.3.1. Patient Recruitment Process
3.3.2. Challenges Associated with Patient Recruitment
3.3.3. Strategies to Improve Patient Recruitment
3.3.4. Ethical Considerations
3.4. Outsourcing Patient Recruitment
3.4.1. Patient Recruitment-related Services
3.5. Patient Retention
3.5.1. Patient Retention-related Services
3.6. Concluding Remarks
4. PATIENT OUTREACH METHODS
4.1. Chapter Overview
4.2. Patient Outreach Methods
4.2.1. Traditional Patient Outreach Methods
4.2.1.1. Physician Referrals
4.2.1.2. Television
4.2.1.3. Radio
4.2.1.4. Print Media
4.2.1.5. Direct Mail Campaign
4.2.1.6. Cold Call / Call Centre
4.2.1.7. Advantages and Limitations of Traditional Media
4.2.2. Emerging Patient Outreach Methods
4.2.2.1. Social Media
4.2.2.1.1. Geo-Social Media
4.2.2.1.2. Social Networking Websites
4.2.2.1.3. Advantages and Limitations of Social Media
4.2.2.2. Mobile / Software Applications
4.2.2.3. Patient Networks
4.2.2.4. Patient Advocacy Groups
4.2.2.5. Electronic Medical Records (EMRs) / Electronic Health Records (EHRs) and Other Health Registries
4.2.2.6. Search Engine Marketing / Artificial Intelligence-based Marketing
4.2.2.7. Over-the-top (OTT) Media Platforms
4.2.2.8. Indication Specific Events for Patients
4.2.3. Best Practices / Recommendations for Patient Outreach
5. MARKET LANDSCAPE
5.1. Chapter Overview
5.2. Patient Recruitment and Retention Service Providers: Overall Market Landscape
5.2.1. Analysis by Year of Establishment
5.2.2. Analysis by Company Size
5.2.3. Analysis by Location of Headquarters
5.2.4. Analysis by Company Size and Location of Headquarters
5.2.5. Analysis by Patient Recruitment and Retention Services Offered
5.2.6. Analysis by Patient Outreach Methods
5.2.7. Analysis by Patient Recruitment Associated Service(s) Offered
5.2.8. Analysis by Patient Retention Method(s) Used
5.2.9. Analysis by Geographical Reach
5.2.10. Analysis by Therapeutic Expertise
5.2.11. Information on Payment Model, Recruitment Technology / Platform and Regulatory Compliance Status
6. COMPANY COMPETITIVENESS ANALYSIS
6.1. Chapter Overview
6.2. Assumptions and Key Parameters
6.3. Methodology
6.4. Patient Recruitment and Retention Service Providers: Company Competitiveness Analysis
6.4.1. Competitiveness Analysis: Small Companies
6.4.2. Competitiveness Analysis: Mid-Sized Companies
6.4.3. Competitiveness Analysis: Large and Very Large Companies
7. COMPANY PROFILES: PATIENT RECRUITMENT AND RETENTION SERVICES PROVIDERS IN NORTH AMERICA
7.1. Chapter Overview
7.2. BBK Worldwide (A Publicis Health Company)
7.2.1. Company Overview
7.2.2. Patient Recruitment and Retention Services Portfolio
7.2.3. Recent Developments and Future Outlook
7.3. Continuum Clinical
7.3.1. Company Overview
7.3.2. Patient Recruitment and Retention Services Portfolio
7.3.3. Recent Developments and Future Outlook
7.4. IQVIA
7.4.1. Company Overview
7.4.2. Patient Recruitment and Retention Services Portfolio
7.4.3. Recent Developments and Future Outlook
7.5. United BioSource (UBC)
7.5.1. Company Overview
7.5.2. Patient Recruitment and Retention Services Portfolio
7.5.3. Recent Developments and Future Outlook
7.6. WCG ThreeWire
7.6.1. Company Overview
7.6.2. Patient Recruitment and Retention Services Portfolio
7.6.3. Recent Developments and Future Outlook
8. COMPANY PROFILES: PATIENT RECRUITMENT AND RETENTION SERVICES PROVIDERS IN EUROPE
8.1. Chapter Overview
8.2. Clariness
8.2.1. Company Overview
8.2.2. Patient Recruitment and Retention Services Portfolio
8.2.3. Recent Developments and Future Outlook
8.3. Ignite Data
8.3.1. Company Overview
8.3.2. Capsule Communications: Patient Recruitment and Retention Services Portfolio
8.3.3. Recent Developments and Future Outlook
8.4. Innovative Trials
8.4.1. Company Overview
8.4.2. Patient Recruitment and Retention Services Portfolio
8.4.3. Recent Developments and Future Outlook
8.5. One Research
8.5.1. Company Overview
8.5.2. Patient Recruitment and Retention Services Portfolio
8.5.3. Recent Developments and Future Outlook
8.6. Orphan Reach
8.6.1. Company Overview
8.6.2. Patient Recruitment and Retention Services Portfolio
8.6.3. Recent Developments and Future Outlook
9. COMPANY PROFILES: PATIENT RECRUITMENT AND RETENTION SERVICES PROVIDERS IN ASIA-PACIFIC AND REST OF THE WORLD
9.1. Chapter Overview
9.2. 3H Medi Solution
9.2.1. Company Overview
9.2.2. Patient Recruitment and Retention Services Portfolio
9.2.3. Recent Developments and Future Outlook
9.3. Buzzreach
9.3.1. Company Overview
9.3.2. Patient Recruitment and Retention Services Portfolio
9.3.3. Recent Developments and Future Outlook
9.4. Current Medical Information Center (CMIC)
9.4.1. Company Overview
9.4.2. Patient Recruitment and Retention Services Portfolio
9.4.3. Recent Developments and Future Outlook
9.5. nRollmed
9.5.1. Company Overview
9.5.2. Patient Recruitment and Retention Services Portfolio
9.5.3. Recent Developments and Future Outlook
9.6. Trialfacts
9.6.1. Company Overview
9.6.2. Patient Recruitment and Retention Services Portfolio
9.6.3. Recent Developments and Future Outlook
10. PARTNERSHIPS AND COLLABORATIONS
10.1. Chapter Overview
10.2. Partnership Models
10.3. Patient Recruitment and Retention Services: List of Partnerships and Collaborations
10.3.1. Analysis by Year of Partnership
10.3.2. Analysis by Type of Partnership
10.3.3. Analysis by Year and Type of Partnership
10.3.4. Analysis by Focus Area
10.3.5. Analysis by Year of Partnership and Focus Area
10.3.6. Analysis by Therapeutic Area
10.3.7. Analysis by Type of Partner
10.3.8. Most Active Players: Analysis by Number of Partnerships
10.3.9. Analysis by Geography
10.3.9.1. Intracontinental and Intercontinental Deals
10.3.9.2. International and Local Deals
11. RECENT TRENDS IN PATIENT RECRUITMENT AND RETENTION
11.1. Chapter Overview
11.1.1. Campaigning on Social Media to Accelerate Patient Recruitment in Clinical Trials
11.1.2. Adoption of Mobile Technologies for Patient Recruitment and Retention
11.1.3. Use of EHR Data to Improve Patient Recruitment Rates
11.1.4. Use of Other Real-World Data Sources to Overcome Patient Enrolment-related Challenges
11.1.5. Use of Artificial Intelligence to Improve Patient Selection
11.1.6. Increase in Adoption of the Virtual Trial Model During the COVID-19 Pandemic
11.1.7. Growing Focus on Conducting Clinical Research in Emerging Markets
12. FUTURE GROWTH OPPORTUNITIES IN PATIENT RECRUITMENT
12.1. Chapter Overview
12.2. Continuous Rise in the Number of Global Clinical Trials
12.3. Rise in Demand for Orphan Drugs and Personalized Medicine
12.4. Increase in Offshoring Clinical Development Activity to Emerging Regions
12.5. Availability of Service Providers Offering One-Stop-Solutions
12.6. Stringent Regulations and Complex Study Protocols Prompting More Outsourcing
12.7. Impact of the COVID-19 Pandemic on Clinical Research Activity
12.8. Technological Advances in Clinical Trial Conduct
13. CASE STUDY: REGULATORY LANDSCAPE OF PATIENT RECRUITMENT
13.1. Chapter Overview
13.2. Regulatory Framework of Patient Recruitment
13.3. Regulations Involved in Patient Recruitment
13.3.1. ICH-GCP Guidelines
13.3.2. Declaration of Helsinki
13.3.3. General Data Privacy Regulation (GDPR)
13.3.4. Health Insurance Portability and Accountability Act (HIPAA)
14. PATIENT RECRUITMENT IN TRIALS FOCUSED ON PERSONALIZED MEDICINES AND RARE DISEASES
14.1. Chapter Overview
14.2. Clinical Trials Focused on Personalized Medicines and Rare Diseases
14.2.1. Key Challenges
14.2.2. Specialized Patient Outreach Methods
14.2.3. Key Players
15. ANALYSIS OF DEMAND FOR CLINICAL TRIAL PARTICIPANTS
15.1. Chapter Overview
15.2. Scope and Methodology
15.3. Clinical Trial Analysis
15.3.1. Analysis by Trial Registration Year and Enrolled Patient Population
15.3.2. Analysis by Trial Phase
15.4. Global Demand for Clinical Trial Participants
15.4.1. Analysis by Enrolled Patient Population
15.4.2. Analysis by Trial Phase
15.4.3. Analysis by Therapeutic Area
15.4.4. Analysis by Enrolled Patient Population and Geography
16. MARKET SIZING AND OPPORTUNITY ANALYSIS
16.1. Chapter Overview
16.2. Forecast Methodology and Key Assumptions
16.3. Global Patient Recruitment Services Market, 2022-2035
16.4. Patient Recruitment Services Market: Analysis by Patient Recruitment Steps, 2022-2035
16.5. Patient Recruitment Services Market: Analysis by Trial Phase, 2022-2035
16.6. Patient Recruitment Services Market: Analysis by Therapeutic Area, 2022-2035
16.7. Patient Recruitment Services Market: Analysis by Geography, 2022-2035
16.7.1. Patient Recruitment Services: Market Attractiveness Analysis by Country, 2022-2035
16.7.2. Patient Recruitment Services Market in North America, 2022-2035
16.7.2.1. Patient Recruitment Services Market in the US: Analysis by Trial Phase, 2022-2035
16.7.2.2. Patient Recruitment Services Market in the US: Analysis by Therapeutic Area, 2022-2035
16.7.2.3. Patient Recruitment Services Market in Canada: Analysis by Trial Phase, 2022-2035
16.7.2.4. Patient Recruitment Services Market in Canada: Analysis by Therapeutic Area, 2022-2035
16.7.3. Patient Recruitment Services Market in Europe, 2022-2035
16.7.3.1. Patient Recruitment Services Market in Germany: Analysis by Trial Phase, 2022-2035
16.7.3.2. Patient Recruitment Services Market in Germany: Analysis by Therapeutic Area, 2022-2035
16.7.3.3. Patient Recruitment Services Market in France: Analysis by Trial Phase, 2022-2035
16.7.3.4. Patient Recruitment Services Market in France: Analysis by Therapeutic Area, 2022-2035
16.7.3.5. Patient Recruitment Services Market in the UK: Analysis by Trial Phase, 2022-2035
16.7.3.6. Patient Recruitment Services Market in the UK: Analysis by Therapeutic Area, 2022-2035
16.7.3.7. Patient Recruitment Services Market in Italy: Analysis by Trial Phase, 2022-2035
16.7.3.8. Patient Recruitment Services Market in Italy: Analysis by Therapeutic Area, 2022-2035
16.7.3.9. Patient Recruitment Services Market in Spain: Analysis by Trial Phase, 2022-2035
16.7.3.10. Patient Recruitment Services Market in Spain: Analysis by Therapeutic Area, 2022-2035
16.7.3.11. Patient Recruitment Services Market in Rest of Europe: Analysis by Trial Phase, 2022-2035
16.7.3.12. Patient Recruitment Services Market in Rest of Europe: Analysis by Therapeutic Area, 2022-2035
16.7.4. Patient Recruitment Services Market in Asia-Pacific, 2022-2035
16.7.4.1. Patient Recruitment Services Market in Japan: Analysis by Trial Phase, 2022-2035
16.7.4.2. Patient Recruitment Services Market in Japan: Analysis by Therapeutic Area, 2022-2035
16.7.4.3. Patient Recruitment Services Market in South Korea: Analysis by Trial Phase, 2022-2035
16.7.4.4. Patient Recruitment Services Market in South Korea: Analysis by Therapeutic Area, 2022-2035
16.7.4.5. Patient Recruitment Services Market in Australia: Analysis by Trial Phase, 2022-2035
16.7.4.6. Patient Recruitment Services Market in Australia: Analysis by Therapeutic Area, 2022-2035
16.7.4.7. Patient Recruitment Services Market in China: Analysis by Trial Phase, 2022-2035
16.7.4.8. Patient Recruitment Services Market in China: Analysis by Therapeutic Area, 2022-2035
16.7.4.9. Patient Recruitment Services Market in India: Analysis by Trial Phase, 2022-2035
16.7.4.10. Patient Recruitment Services Market in India: Analysis by Therapeutic Area, 2022-2035
16.7.5 Patient Recruitment Services Market in Latin America, 2022-2035
16.7.5.1. Patient Recruitment Services Market in Latin America: Analysis by Trial Phase, 2022-2035
16.7.5.2. Patient Recruitment Services Market in Latin America: Analysis by Therapeutic Area, 2022-2035
16.7.6. Patient Recruitment Services Market in Middle East and North Africa, 2022-2035
16.7.6.1. Patient Recruitment Services Market in Middle East and North Africa: Analysis by Trial Phase, 2022-2035
16.7.6.2. Patient Recruitment Services Market in Middle East and North Africa: Analysis by Therapeutic Area, 2022-2035
16.7.7. Patient Recruitment Services Market in Rest of the World, 2022-2035
16.7.7.1. Patient Recruitment Services Market in Rest of the World: Analysis by Trial Phase, 2022-2035
16.7.7.2. Patient Recruitment Services Market in Rest of the World: Analysis by Therapeutic Area, 2022-2035
17. IMPACT OF THE COVID-19 PANDEMIC ON PATIENT RECRUITMENT SERVICES MARKET
17.1. Chapter Overview
17.2. Impact of COVID-19 Pandemic on Clinical Trials
17.2.1. Impact on Opportunity Related to Patient Recruitment Services
17.2.2. Initiatives Undertaken by Key Patient Recruitment and Retention Service Providers
17.2.2.1. Trialspark
17.2.2.2. BBK Worldwide
17.2.2.3. Clariness
17.2.2.4. Clinical Site Services (CSSi)
17.2.2.5. IQVIA
17.3. Key Strategies Adopted to Mitigate the Challenges Associated with Patient Recruitment and Retention
18. CONCLUDING REMARKS
19. EXECUTIVE INSIGHTS
19.1. Chapter Overview
19.2. TrialWire
19.2.1. Company Snapshot
19.2.2. Interview Transcript: Susan Fitzpatrick-Napier, Founder and Director
19.3. Innovative Trials
19.3.1. Company Snapshot
19.3.2. Interview Transcript: Kate Shaw, Chief Executive Officer and Founder, and Marco Lassandro, Marketing and Communications Manager
19.4. Link2Trials
19.4.1. Company Snapshot
19.4.2. Interview Transcript: Simon Klaasen, Managing Partner
19.5. Clariness
19.5.1. Company Snapshot
19.5.2. Interview Transcript: Stefan Mayer-Eggersmann, Chief Commercial Officer
19.6. Continuum Clinical
19.6.1. Company Snapshot
19.6.2. Interview Transcript: Ken Shore, Chief Commercial Officer
19.7. nRollmed
19.7.1. Company Snapshot
19.7.2. Interview Transcript: Hagit Nof, Chief Operation Officer and Business Development Officer
19.8. Seeker Health
19.8.1. Company Snapshot
19.8.2. Interview Transcript: Paul Ivsin, Ex Managing Director
19.9. EVERSANA
19.9.1. Company Snapshot
19.9.2. Interview Transcript: Kasturi Lakhe, Inside Sales Specialist
20. APPENDIX 1: TABULATED DATA
21. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
To view more details on this report, click on the link:
You may also be interested in the following titles:
Cell Therapy Manufacturing Market
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
